These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18541185)

  • 1. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers.
    Baron RC; Rimer BK; Coates RJ; Kerner J; Mullen PD; Chattopadhyay S; Briss PA;
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S26-33. PubMed ID: 18541185
    [No Abstract]   [Full Text] [Related]  

  • 2. Introducing the community guide's reviews of evidence on interventions to increase screening for breast, cervical, and colorectal cancers.
    Breslow RA; Rimer BK; Baron RC; Coates RJ; Kerner J; Wilson KM; Lee NC; Mullen PD; Coughlin SS; Briss PA
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S14-20. PubMed ID: 18541183
    [No Abstract]   [Full Text] [Related]  

  • 3. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives.
    Sabatino SA; Habarta N; Baron RC; Coates RJ; Rimer BK; Kerner J; Coughlin SS; Kalra GP; Chattopadhyay S;
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S67-74. PubMed ID: 18541190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for client- and provider-directed interventions to increase breast, cervical, and colorectal cancer screening.
    Task Force on Community Preventive Services
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S21-5. PubMed ID: 18541184
    [No Abstract]   [Full Text] [Related]  

  • 5. How not to get lost in translation: implementing the recommendations and identifying research gaps.
    Glanz K; Melvin C
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S3-5. PubMed ID: 18541186
    [No Abstract]   [Full Text] [Related]  

  • 6. Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review.
    Baron RC; Rimer BK; Breslow RA; Coates RJ; Kerner J; Melillo S; Habarta N; Kalra GP; Chattopadhyay S; Wilson KM; Lee NC; Mullen PD; Coughlin SS; Briss PA;
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S34-55. PubMed ID: 18541187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to improve cancer screening: opportunities in the workplace.
    Hannon PA; Harris JR
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S10-3. PubMed ID: 18541182
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
    Knudsen AB; McMahon PM; Gazelle GS
    J Clin Oncol; 2007 Jan; 25(2):203-8. PubMed ID: 17210941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
    Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
    Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness research and cancer screening in the United States and Europe.
    Howard DH
    Med Decis Making; 2009; 29(6):NP12-3. PubMed ID: 19959803
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing cancer: using health dollars wisely.
    Wasserman S
    NCSL Legisbrief; 2004 Feb; 12(8):1-2. PubMed ID: 14974484
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands].
    van den Berg M; de Wit GA; Vijgen SM; Busch MC; Schuit AJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1329-34. PubMed ID: 18661860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to improve cancer screening: commentary from a health services research perspective.
    Yabroff KR
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S6-9. PubMed ID: 18541189
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The futility and lack of cost-effectiveness in screening for cancer.
    Handler S
    Minn Med; 1992 Dec; 75(12):13-6. PubMed ID: 1470083
    [No Abstract]   [Full Text] [Related]  

  • 18. Using lay health advisors to promote breast and cervical cancer screening among Latinas: a review.
    Martínez-Donate AP
    WMJ; 2009 Aug; 108(5):259-62. PubMed ID: 19743759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.
    Barbiere JM; Lyratzopoulos G
    Gastroenterology; 2009 Dec; 137(6):1869-76. PubMed ID: 19840798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.